A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

NCT03544229 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Gastroparesis
Idiopathic Gastroparesis

Interventions

DRUG: TAK-906 Maleate
DRUG: Placebo

Sponsor

Millennium Pharmaceuticals, Inc.